Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies-Reference-Cited by-同舟云学术

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

Published:2000-11 Issue:12 Volume:39 Page:2318-2328
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Hutson P.H.,Barton C.L.,Jay M.,Blurton P.,Burkamp F.,Clarkson R.,Bristow L.J.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference55 articles.

1. Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera;Abramowski;Neuropharmacology,1995

2. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence;Arnt;Neuropsychopharmacology,1998

3. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat;Azmitia;Journal of Comparative Neurology,1978

4. Phencyclidine-induced increase of nucleus accumbens dopamine efflux and locomotor activity is enhanced by the 5-HT2C/2B receptor antagonist SB 221284;Barton;British Journal of Pharmacology,1999

5. The glycine/NMDA receptor antagonist, R-(+)-HA-966 blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents;Bristow;British Journal of Pharmacology,1993

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies;Expert Opinion on Pharmacotherapy;2024-06-12

2. A Kpna1-deficient psychotropic drug-induced schizophrenia model mouse for studying gene–environment interactions;Scientific Reports;2024-02-09

3. Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence;Progress in Brain Research;2021

4. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications;Progress in Neurobiology;2017-04

5. New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders;Pharmacology & Therapeutics;2016-01